Pages that link to "Q40886912"

The following pages link to New highly specific agonistic peptides for human melanocortin MC(1) receptor (Q40886912):

Displaying 18 items.

• Detection of regions in the MC1 receptor of importance for the selectivity of the MC1 receptor super-selective MS04/MS05 peptides (Q30666860) (← links)
• Phage display of random peptide libraries: applications, limits, and potential (Q31039269) (← links)
• Identification of hNopp140 as a binding partner for doxorubicin with a phage display cloning method (Q31041425) (← links)
• Identification of antiviral mimetic peptides with interferon alpha-2b-like activity from a random peptide library using a novel functional biopanning method (Q33330222) (← links)
• Malignant melanoma and melanocortin 1 receptor. (Q33782773) (← links)
• Melanocortin 1 receptor agonists reduce proteinuria (Q34117792) (← links)
• The synthetic melanocortin (CKPV)2 exerts anti-fungal and anti-inflammatory effects against Candida albicans vaginitis via inducing macrophage M2 polarization (Q34330822) (← links)
• Effects of melanocortin 1 receptor agonists in experimental nephropathies (Q34402391) (← links)
• Crucial role of the melanocortin receptor MC1R in experimental colitis (Q35760868) (← links)
• Subcellular trafficking and transfection efficacy of polyethylenimine-polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-1. (Q36339369) (← links)
• MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy (Q36980645) (← links)
• BacMam system for FRET-based cAMP sensor expression in studies of melanocortin MC1 receptor activation (Q39335609) (← links)
• A retro‐inverso α‐melanocyte stimulating hormone analog with MC1R‐binding selectivity (Q39618048) (← links)
• Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying affinity to melanocortin receptors (Q40301775) (← links)
• Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activation. (Q46863445) (← links)
• Dissection of the Anti-Inflammatory Effect of the Core and C-Terminal (KPV) α-Melanocyte-Stimulating Hormone Peptides (Q47908771) (← links)
• Regulation of TNF-alpha secretion by a specific melanocortin-1 receptor peptide agonist. (Q53652483) (← links)
• PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactions (Q73849375) (← links)